Smith & Nephew Stock Price, News & Analysis

Smith+Nephew (LSE: SN, NYSE: SNN) is showcasing advanced joint repair solutions at the AOSSM Annual Meeting in Colorado from July 13-17, 2022. Key highlights include the REGENETEN Bioinductive Implant, aimed at treating 17 million individuals with rotator cuff diseases in the U.S., which has shown potential to expedite healing and reduce re-tears. Other innovations include the Reimagine Reconstruction portfolio for knee injuries and the CAP-FIX Suture Passer for hip repairs. The event will also feature live surgery demos and educational opportunities for surgeons.

Smith+Nephew (NYSE:SNN) has launched the WOUND COMPASS™ Clinical Support App, aimed at assisting healthcare professionals in wound assessment and decision-making. The app addresses practice variation, which negatively affects patient outcomes in chronic wound care. Validated by over 70 clinicians, it enhances nurse confidence in assessments, with 83% of non-specialists reporting it simplifies evaluations. Available on both Apple and Android, the app categorizes wounds and offers tailored treatment guidance. This innovation is part of Smith+Nephew’s commitment to improving patient care and outcomes.

Smith+Nephew (NYSE: SNN) successfully performed its first robotic-assisted surgery using the LEGION CONCELOC Cementless Total Knee System. Conducted by Dr. Cyna Khalily in Louisville, KY, this milestone enhances its portfolio of cementless knee implants and robotic technology. The procedure employs the CORI Surgical System, designed to optimize surgical efficiency by eliminating preoperative CT imaging, thus reducing costs and radiation exposure. This innovation reflects Smith+Nephew's commitment to improving surgical outcomes and employing advanced materials for knee arthroplasty.

Smith+Nephew (LSE: SN, NYSE: SNN) published a peer-reviewed article in Wounds International predicting a potential release of 3.5 billion hours of nursing time by 2030 through shared care in chronic wound management and the use of long-wear advanced foam dressings. The study highlights a global nursing shortage of 10.6 million by 2030, emphasizing the need for efficient care practices. The implementation of shared care practices could lead to an annual reallocation of over 433 million hours of clinical nursing time worldwide, enhancing patient care and optimizing resources.

Smith+Nephew (NYSE:SNN) announced the successful first total hip arthroplasty (THA) using its RI.HIP MODELER at Duke Regional Hospital. The procedure was performed by Dr. Rhett Hallows, who utilized the preoperative spinopelvic assessment tool to enhance surgical planning. In April, Dr. Thorsten Seyler executed the inaugural RI.HIP NAVIGATION procedure on the CORI Surgical System. This system aids in precise component alignment, addressing challenges in hip surgery. The innovations are expected to drive growth for the CORI Surgical System.

Healiva® announced its acquisition of two innovative cell therapy assets from Smith+Nephew (NYSE:SNN), enhancing its portfolio of chronic wound care solutions. The first asset, EpiDex®, is an autologous epidermal equivalent that facilitates surgery-free healing for chronic venous leg ulcers (VLUs), while the second, healiva®002, is an allogeneic cell therapy proven effective for hard-to-treat VLUs. This acquisition aims to expedite market launch and addresses the urgent need for effective treatments for the 36 million people suffering from chronic wounds worldwide.

Smith+Nephew (LSE: SN, NYSE: SNN) announced a peer-reviewed study published in the Advances in Wound Care Journal, demonstrating that GRAFIX Cryopreserved Placental Membrane significantly cuts diabetic foot ulcer (DFU) recurrence rates. The study analyzed over 1.3 million Medicare patients and showed a reduction of up to 58.5% in ulcer recurrence at 365 days compared to competitors. With Medicare patients spending an estimated $6-18 billion annually on DFU treatment, GRAFIX has gained coverage from Medicare and major payers, reinforcing its potential financial advantage.

Smith+Nephew (NYSE:SNN) will showcase its innovations in Orthopaedic Reconstruction and Robotics at the AAOS 2022 Annual Meeting in Chicago. The highlight is the launch of the LEGION CONCELOC Cementless Total Knee System, marking Smith+Nephew as the only U.S. company with a complete cementless knee portfolio. Their ABLE Advanced Anterior Approach for Total Hip Arthroplasty is also noteworthy for its efficiency and low complication rates. The CORI Surgical System, offering expanded indications in orthopedic procedures, will also be presented, enhancing Smith+Nephew's robotic-assisted surgery capabilities.

Smith+Nephew (LSE:SN, NYSE:SNN) announced the showcase of its latest Sports Medicine innovations at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago, IL. Key products include the FAST-FIX™ FLEX Meniscal Repair System, which enhances meniscus repair opportunities, and the INTELLIO™ Connected Tower, which integrates surgical technologies for improved workflow. Other innovations include the WEREWOLF™ FASTSEAL 6.0 Hemostasis Wand and REGENETEN™ Bioinductive Implant, aimed at better patient outcomes and efficiency in joint surgeries.